Yutaka Okagawa, Keita Seto, Koki Yoshida, Kota Hanada, Sota Hirokawa, Yusuke Tomita, Kaho Tokuchi, Takeyoshi Minagawa, Kohtaro Morita, Kei Yane, Michiaki Hirayama, Hitoshi Kondo, Tetsuya Sumiyoshi
{"title":"Clinicopathological features of early-onset colorectal cancer in Japanese patients: a single-center retrospective study.","authors":"Yutaka Okagawa, Keita Seto, Koki Yoshida, Kota Hanada, Sota Hirokawa, Yusuke Tomita, Kaho Tokuchi, Takeyoshi Minagawa, Kohtaro Morita, Kei Yane, Michiaki Hirayama, Hitoshi Kondo, Tetsuya Sumiyoshi","doi":"10.1186/s12876-025-03725-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The incidence of early-onset colorectal cancer (EoCRC), defined as CRC diagnosed at < 50 years of age, is increasing globally. However, only a few studies are reported from Japan, and the clinicopathological features of EoCRC in Japanese patients remain unknown.</p><p><strong>Methods: </strong>We retrospectively investigated consecutive Japanese patients who were pathologically diagnosed with invasive CRC at our hospital from January 2015 to December 2021. Patients were categorized into those who were diagnosed with CRC at < 50 years (early-onset group) and ≥ 50 years (late-onset group) of age. We compared the clinicopathological findings between the two groups.</p><p><strong>Results: </strong>The analysis included 731 patients. EoCRC was diagnosed in 46 patients (6.3% of all patients). Of them, 41.3% demonstrated a positive fecal immunochemical test (FIT) for CRC screening as a diagnostic opportunity, which was significantly higher than that in the late-onset group (p = 0.032). Rectal cancer was significantly more prevalent in the early-onset group compared to the late-onset group (45.7% vs. 26.4%, p < 001). No significant difference in the rate of clinical stage at presentation was found between the two groups. Furthermore, patients with positive FIT were more likely diagnosed at an earlier stage.</p><p><strong>Conclusions: </strong>EoCRC among Japanese patients tends to occur on the rectum and is more frequently diagnosed with FIT screening compared to late-onset CRC. Patients with advanced stage were diagnosed by symptoms, indicating the usefulness of FIT screening in diagnosing EoCRC at an early stage.</p>","PeriodicalId":9129,"journal":{"name":"BMC Gastroenterology","volume":"25 1","pages":"156"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11899674/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12876-025-03725-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The incidence of early-onset colorectal cancer (EoCRC), defined as CRC diagnosed at < 50 years of age, is increasing globally. However, only a few studies are reported from Japan, and the clinicopathological features of EoCRC in Japanese patients remain unknown.
Methods: We retrospectively investigated consecutive Japanese patients who were pathologically diagnosed with invasive CRC at our hospital from January 2015 to December 2021. Patients were categorized into those who were diagnosed with CRC at < 50 years (early-onset group) and ≥ 50 years (late-onset group) of age. We compared the clinicopathological findings between the two groups.
Results: The analysis included 731 patients. EoCRC was diagnosed in 46 patients (6.3% of all patients). Of them, 41.3% demonstrated a positive fecal immunochemical test (FIT) for CRC screening as a diagnostic opportunity, which was significantly higher than that in the late-onset group (p = 0.032). Rectal cancer was significantly more prevalent in the early-onset group compared to the late-onset group (45.7% vs. 26.4%, p < 001). No significant difference in the rate of clinical stage at presentation was found between the two groups. Furthermore, patients with positive FIT were more likely diagnosed at an earlier stage.
Conclusions: EoCRC among Japanese patients tends to occur on the rectum and is more frequently diagnosed with FIT screening compared to late-onset CRC. Patients with advanced stage were diagnosed by symptoms, indicating the usefulness of FIT screening in diagnosing EoCRC at an early stage.
背景:早发性结直肠癌(EoCRC)的发病率,定义为以下诊断的CRC:方法:我们回顾性调查2015年1月至2021年12月在我院病理诊断为浸润性CRC的连续日本患者。患者被分为被诊断为结直肠癌的患者:结果分析包括731例患者。46例患者被诊断为EoCRC(占所有患者的6.3%)。其中41.3%将粪便免疫化学试验(FIT)阳性作为CRC筛查的诊断机会,显著高于晚发组(p = 0.032)。与晚发性CRC相比,早发性CRC在日本患者中的发病率更高(45.7% vs. 26.4%)。结论:与晚发性CRC相比,日本患者的EoCRC倾向于发生在直肠,并且更常通过FIT筛查诊断。晚期患者通过症状诊断,提示FIT筛查在早期诊断EoCRC的有效性。
期刊介绍:
BMC Gastroenterology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of gastrointestinal and hepatobiliary disorders, as well as related molecular genetics, pathophysiology, and epidemiology.